CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells.
Ito S, Ueno A, Ueda T, Nakagawa H, Taniguchi H, Kayukawa N, Fujihara-Iwata A, Hongo F, Okihara K, Ukimura O.
Ito S, et al. Among authors: hongo f.
Oncotarget. 2018 Apr 3;9(25):17645-17655. doi: 10.18632/oncotarget.24824. eCollection 2018 Apr 3.
Oncotarget. 2018.
PMID: 29707137
Free PMC article.